Biohaven (BHVN) Stock Is Trending Overnight — Here's What You Should Know

Benzinga_recent_news01-15

Biohaven Ltd. (NYSE:BHVN) shares are trending on Thursday. Check out the current price of BHVN stock here. Shares of the Connecticut-based biopharmaceutical company surged 3.42% in after-hours trading...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603622805?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/14/Stock-Market-Analysis-With-Candlestick-C.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-01-15 10:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603622805","market":"sh","top_or_hot":-1,"title":"Biohaven (BHVN) Stock Is Trending Overnight — Here's What You Should Know","media":"Benzinga_recent_news","content":"<div>\n<p>Biohaven Ltd. (NYSE:BHVN) shares are trending on Thursday.\nCheck out the current price of BHVN stock here.\nShares of the Connecticut-based biopharmaceutical company surged 3.42% in after-hours trading...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/01/49925544/biohaven-bhvn-stock-is-trending-overnight-heres-what-you-should-know\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biohaven (BHVN) Stock Is Trending Overnight — Here's What You Should Know</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiohaven (BHVN) Stock Is Trending Overnight — Here's What You Should Know\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-15 10:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/26/01/49925544/biohaven-bhvn-stock-is-trending-overnight-heres-what-you-should-know><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biohaven Ltd. (NYSE:BHVN) shares are trending on Thursday.\nCheck out the current price of BHVN stock here.\nShares of the Connecticut-based biopharmaceutical company surged 3.42% in after-hours trading...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/01/49925544/biohaven-bhvn-stock-is-trending-overnight-heres-what-you-should-know\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RSI","symbol_name":"Rush Street Interactive, Inc.","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/26/01/49925544/biohaven-bhvn-stock-is-trending-overnight-heres-what-you-should-know","article_id":"2603622805","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/14/Stock-Market-Analysis-With-Candlestick-C.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/01/49925544/biohaven-bhvn-stock-is-trending-overnight-heres-what-you-should-know","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2603622805","pubTimestamp":1768445280,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Biohaven Ltd. shares surged 3.42% in after-hours trading following an SEC filing that detailed investor presentations and updates on its drug pipeline.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RSI":"Rush Street Interactive, Inc.","BHVN":"Biohaven Pharmaceutical Holding Co Ltd.","BK4139":"生物科技","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4150":"赌场与赌博"},"translate_title":"Biohaven(BHVN)股票隔夜流行-以下是您应该了解的内容","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RSI":1,"BHVN":1.5},"content_text":"Biohaven Ltd. (NYSE:BHVN) shares are trending on Thursday.\nCheck out the current price of BHVN stock here.\nShares of the Connecticut-based biopharmaceutical company surged 3.42% in after-hours trading on Wednesday to $12.10.\nAccording to Benzinga Pro data, the stock closed at $11.70, up 6.65% in regular trading session.\nBiohaven filed a Securities and Exchange Commission filing on Monday, disclosing an investor presentation made that day.\nThe presentation was furnished under Item 7.01 Regulation FD Disclosure and attached as Exhibit 99.1, a filing category used to broadly share material information with the public in compliance with fair disclosure rules.\nBiohaven also highlighted portfolio progress at the 44th Annual J.P. Morgan Healthcare Conference, according to a company press release dated Monday.\nBHV-1400, a TRAP degrader for IgA nephropathy, achieved mean Gd-IgA1 reductions exceeding 60% within hours in Phase 1 studies, according to the company press release. Two patients showed clinical improvements: one experienced complete hematuria resolution within weeks, while another demonstrated greater than 60% proteinuria reduction and 24% glomerular filtration rate increase.\nVlad Coric, chairman and CEO, said the data \"continues to signal the important role that this transformative science can have in the treatment of immunological disease.\"\nBiohaven dosed its first patient with taldefgrobep in a Phase 2 obesity trial in the fourth quarter of 2025, with the 24-week study enrolling about 150 participants and topline results expected in 2026.\nThe company also anticipates pivotal topline results for opakalim in focal epilepsy in 2026 and plans to initiate pivotal trials for BHV-1400 and BHV-1300 in Graves’ disease.\nThe clinical-stage biotech has a Relative Strength Index (RSI) of 54.80.\nOver the past 12 months, Biohaven Ltd.’s stock has declined 67.11%, highlighting ongoing challenges and signaling that traders should exercise caution.\nWith a market capitalization of $1.55 billion, the company's shares have traded between a 52-week high of $44.28 and a 52-week low of $7.48.\nCurrently trading at 11.46% of its 52-week range, Biohaven Ltd.’s stock is closer to its recent lows than its highs, suggesting limited upside potential unless it can overcome key resistance levels.\nBenzinga’s Edge Stock Rankings indicate that BHVN is showing short-term upward momentum while experiencing medium- and long-term consolidation. Know how its momentum lines up with other well-known names.\nPhoto Courtesy: Digineer Station on Shutterstock.com\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603622805","isCrawlerRequest":true}